"India Pharmaceuticals & Healthcare Report Q1 2016" Now Available at Fast Market Research
India's pricing regi me will continue to weigh on its pharmaceutical sector's growth potential. Affecting both local and multinational pharmaceutical firms, the price cuts can be substantial, thereby compounding the uncertainty created, especially as the decision process is carried out with limited consultation with the industry. Risks will also become more acute as the government looks to reform the pricing regime following the Supreme Court's verdict that existing prices are set at unreasonably high levels.
View full press release